Elite Pharmaceuticals, Inc. (ELTP)
OTCMKTS
· Delayed Price · Currency is USD
0.6000
+0.0002 (0.03%)
Jul 3, 2025, 1:00 PM EDT
Elite Pharmaceuticals Revenue
In the fiscal year ending March 31, 2025, Elite Pharmaceuticals had annual revenue of $84.04M with 48.42% growth. Elite Pharmaceuticals had revenue of $32.00M in the quarter ending March 31, 2025, with 78.26% growth.
Revenue
84.04M
Revenue Growth
+48.42%
P/S Ratio
7.61
Revenue / Employee
1.24M
Employees
64
Market Cap
639.84M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 84.04M | 27.42M | 48.42% |
| Mar 31, 2024 | 56.63M | 22.47M | 65.79% |
| Mar 31, 2023 | 34.16M | 1.89M | 5.87% |
| Mar 31, 2022 | 32.26M | 6.88M | 27.11% |
| Mar 31, 2021 | 25.38M | 7.39M | 41.05% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo, Inc. | 1.73B |
| Veradigm | 588.02M |
| Tian'an Technology Group | 1.78M |
| Glass House Brands | 215.62M |
| American Oncology Network | 1.76B |
| Northwest Biotherapeutics | 1.47M |
| Silence Therapeutics | 27.70M |
| BioStem Technologies | 332.45M |
Elite Pharmaceuticals News
- 2 days ago - Elite Pharmaceuticals, Inc. (ELTP) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 2 days ago - Elite Pharmaceuticals reports FY results - Seeking Alpha
- 3 days ago - Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2025 and Provides Conference Call Information - Newsfile Corp
- 10 days ago - Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Fiscal Year 2025 Financial Results on July 1, 2025 - Newsfile Corp
- 17 days ago - Elite Pharmaceuticals Reports Positive Results from a Pivotal Bioequivalence Study - Newsfile Corp
- 2 months ago - Elite Pharmaceuticals Announces Commercial Launch of Oxycodone and Acetaminophen Tablets - Newsfile Corp
- 4 months ago - Elite Pharmaceuticals, Inc. Announces First Shipment of Product from New Facility and Packaging Line - Newsfile Corp
- 4 months ago - Elite Pharmaceuticals Inc (ELTP) Q3 2025 Earnings Call Highlights: Record Revenue Growth Amid ... - GuruFocus